HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Deepak Cyril D'Souza Selected Research

Neurobehavioral Manifestations

4/2016Human Laboratory Studies on Cannabinoids and Psychosis.
1/2016Cannabinoids and Psychosis.
6/2014Impact of Cannabis Use on the Development of Psychotic Disorders.
1/2014Gone to Pot - A Review of the Association between Cannabis and Psychosis.
5/2010[Behavioral, cognitive and psychophysiological effects of cannabinoids: relevance to psychosis and schizophrenia].
10/2009Cannabis and psychosis/schizophrenia: human studies.
4/2009Cannabinoids and psychosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Deepak Cyril D'Souza Research Topics

Disease

25Psychotic Disorders (Schizoaffective Disorder)
03/2022 - 08/2004
24Schizophrenia (Dementia Praecox)
11/2020 - 08/2004
7Neurobehavioral Manifestations
04/2016 - 04/2009
4Substance-Related Disorders (Drug Abuse)
12/2020 - 08/2006
3Cognitive Dysfunction
01/2020 - 07/2008
2Hallucinations (Hallucination)
12/2020 - 01/2020
2Disease Susceptibility (Diathesis)
01/2016 - 06/2014
2Alcoholism (Alcohol Abuse)
06/2014 - 08/2006
1Major Depressive Disorder (Major Depressive Disorders)
01/2022
1Treatment-Resistant Depressive Disorder
01/2022
1Psychomotor Disorders
01/2020
1Mental Disorders (Mental Disorder)
01/2020
1Substance Withdrawal Syndrome (Withdrawal Symptoms)
01/2019
1Acquired Immunodeficiency Syndrome (AIDS)
01/2016
1Nausea
01/2016
1Marijuana Use
01/2016
1Multiple Sclerosis
01/2016
1Vomiting
01/2016
1Cachexia
01/2016
1Neuralgia (Stump Neuralgia)
01/2016
1Tachycardia (Tachyarrhythmias)
09/2008
1Psychomotor Agitation (Akathisia)
03/2005
1Dyskinesias (Dyskinesia)
03/2005

Drug/Important Bio-Agent (IBA)

20CannabinoidsIBA
03/2022 - 08/2004
7Dronabinol (THC)FDA LinkGeneric
12/2020 - 03/2005
6KetamineFDA LinkGeneric
01/2022 - 08/2006
6Cannabinoid Receptors (Cannabinoid Receptor)IBA
01/2016 - 08/2004
5Biological ProductsIBA
01/2020 - 01/2007
4EndocannabinoidsIBA
03/2022 - 01/2016
4Antipsychotic Agents (Antipsychotics)IBA
01/2021 - 03/2005
4NicotineFDA Link
01/2018 - 11/2012
3gamma-Aminobutyric Acid (GABA)IBA
11/2015 - 01/2006
3N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2014 - 03/2012
3Hydrocortisone (Cortisol)FDA LinkGeneric
09/2008 - 08/2004
2Pharmaceutical PreparationsIBA
10/2020 - 12/2015
2Glycine (Aminoacetic Acid)FDA LinkGeneric
01/2018 - 03/2012
2N-Methylaspartate (NMDA)IBA
01/2014 - 08/2006
2Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
11/2012 - 03/2012
1Mechanistic Target of Rapamycin Complex 1IBA
01/2022
1N,N-Dimethyltryptamine (Dimethyltryptamine)IBA
01/2022
15-HT2A Serotonin Receptor (5 HT2A Receptor)IBA
01/2020
1Therapeutic UsesIBA
01/2020
1GSK215083IBA
01/2020
1Indicators and Reagents (Reagents)IBA
01/2020
1serotonin 6 receptorIBA
01/2020
1N-nitrosoiminodiacetic acidIBA
01/2019
1N- pyridazin- 3- yl- 4- (3- ((5- (trifluoromethyl)pyridin- 2- yl)oxy)benzylidene)piperidine- 1- carboxamideIBA
01/2019
11-methyl-1H-imidazole-4-carboxylic acid (3- chloro- 4- fluoro- benzyl)- (3- methyl- 3- aza- bicyclo(3.1.0) hex-6-ylmethyl)amideIBA
01/2018
1SmokeIBA
01/2018
1Cannabinoid Receptor AgonistsIBA
04/2016
1Opioid Analgesics (Opioids)IBA
01/2016
1Amphetamine (Amfetamine)FDA LinkGeneric
11/2015
1Dopamine (Intropin)FDA LinkGeneric
11/2015
1N- methyl- N- (6- methoxy- 1- phenyl- 1,2,3,4- tetrahydronaphthalen- 2- ylmethyl)aminomethylcarboxylic acidIBA
03/2012
1Serine (L-Serine)FDA Link
03/2012
1AcidsIBA
03/2012
1Glutamic Acid (Glutamate)FDA Link
03/2012
1GABA-A Receptors (GABA(A) Receptor)IBA
02/2011
1iomazenilIBA
02/2011
1GABA Receptors (GABA Receptor)IBA
02/2011
1Butyric Acid (Butanoic Acid)IBA
02/2011
1CB1 Cannabinoid Receptor (CB1 Receptor)IBA
01/2007
1Glutamate Receptors (Glutamate Receptor)IBA
08/2006
1Naltrexone (ReVia)FDA LinkGeneric
08/2006
1Opiate AlkaloidsIBA
08/2006
1Serotonin (5 Hydroxytryptamine)IBA
01/2006
1ProlactinIBA
03/2005

Therapy/Procedure

2Self Medication
01/2018 - 04/2016
2Drug Therapy (Chemotherapy)
01/2016 - 08/2006
1Therapeutics
01/2021